Advertisement

  • Forward Look

    What’s Next?

    Using fecal transplants to improve immunotherapy response

    by Natalie Slivinski

  • Facts and Stats

    Summer 2021

    vol 11 | issue 2
    A knowledge of the different types of skin cancer can help you remain vigilant.

  • How Long Do Immunotherapy Side Effects Last?

    For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.

    by Anna Goshua

  • Worth the Wait

    Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.

    by Sharon Tregaskis

  • Our Own Words

    People with cancer and their loved ones find ways for their voices to be heard without filters.

    by Bradley Jones

  • Survivor Profile

    Still in the Game

    ESPN reporter Holly Rowe worked through melanoma treatment.

    by Lindsey Konkel

  • Q&A

    Dissecting Mental Illness

    Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain.

    by Marci A. Landsmann

  • Pembrolizumab Shows Further Promise for Melanoma

    In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.

    by Brad Jones

  • Forward Look

    Tackling Drug Resistance

    Researchers are studing new ways to keep treatments working longer.

    by Stephen Ornes

  • Survivor Profile

    Living in the Here and Now

    A metastatic melanoma survivor is hopeful but realistic as new treatments become available.

    by Jenny Song

Advertisement
Advertisement

From the AACR

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR